Target intelligence / Profile preview

Adenylate-uridylate-rich element-containing messenger RNA (ARE-mRNA)

Target
ARE-mRNA
Molecular classification
Messenger RNA, Regulatory RNA element
01

Overview

Adenylate-uridylate-rich element-containing messenger RNAs (ARE-mRNAs) are a class of transcripts characterized by conserved AU-rich sequences in their 3' untranslated regions (3' UTRs) that dictate mRNA half-life and translation (Source: PubMed, PMID: 17486126). These elements act as binding sites for ARE-binding proteins (ARE-BPs) like HuR, which stabilizes transcripts, and TTP, which promotes their degradation (Source: UniProt, P26678; P12429). ARE-mRNAs typically encode potent regulatory proteins such as cytokines, growth factors, and proto-oncogenes, making their precise regulation essential for cellular homeostasis (Source: Nature Reviews Molecular Cell Biology). In diseases like cancer and chronic inflammation, the ARE-mediated decay pathway is often subverted, leading to the stabilization of oncogenic or pro-inflammatory transcripts (Source: Journal of Biological Chemistry). Therapeutic targeting of ARE-mRNAs involves small molecules that disrupt the interaction between AREs and stabilizing proteins like HuR, or antisense oligonucleotides designed to modulate specific transcript stability (Source: PMC, PMC4133797).

Other names
AU-rich element-containing mRNAARE-mRNA3' UTR AU-rich elementAdenylate-uridylate-rich element
02

Mechanism of action

Modulation of mRNA stability and translation by targeting RNA-protein interactions or using antisense technology

03

Biological functions

mRNA stability regulationmRNA degradationTranslation regulationPost-transcriptional gene regulation
04

Disease associations

CancerInflammationAutoimmune diseaseCardiovascular diseaseNeurodegenerative disease
05

Safety considerations

Potential for broad off-target effects due to the prevalence of AREs in the transcriptomeRisk of systemic toxicity from disrupting essential gene regulationChallenges in achieving transcript-specific modulation
06

Interacting drugs

MS-444

3 more in the full profile.

07

Biomarkers

HuR (ELAVL1) expression levelsTTP (ZFP36) expression levelsTNF-alpha mRNA stabilityIL-6 mRNA levels

Beyond the preview

Go deeper on Adenylate-uridylate-rich element-containing messenger RNA (ARE-mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adenylate-uridylate-rich element-containing messenger RNA (ARE-mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call